Literature DB >> 16773277

Thalidomide-induced symptomatic third-degree atrioventricular block.

M Hinterseer, A Becker, S Kääb, N Lang, M Näbauer, G Steinbeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16773277     DOI： 10.1007/s00392-006-0401-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  19 in total

Review 1.  A review of thalidomide's history and current dermatological applications.

Authors:  Anthony J Perri; Sylvia Hsu
Journal:  Dermatol Online J       Date:  2003-08

2.  THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS.

Authors:  J SHESKIN
Journal:  Clin Pharmacol Ther       Date:  1965 May-Jun       Impact factor: 6.875

3.  Thalidomide-induced bradycardia and its management.

Authors:  John Coutsouvelis; Carmela E Corallo
Journal:  Med J Aust       Date:  2004-04-05       Impact factor: 7.738

4.  [Guidelines for heart pacemaker therapy].

Authors:  B Lemke; B Nowak; D Pfeiffer
Journal:  Z Kardiol       Date:  2005-10

5.  Safety profile of thalidomide after 53 weeks of oral administration in beagle dogs.

Authors:  S K Teo; M G Evans; M J Brockman; J Ehrhart; J M Morgan; D I Stirling; S D Thomas
Journal:  Toxicol Sci       Date:  2001-01       Impact factor: 4.849

Review 6.  Thalidomide: emerging role in cancer medicine.

Authors:  Paul Richardson; Teru Hideshima; Kenneth Anderson
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

7.  Dissimilar atrial rhythms: coexistence of reentrant atrial tachycardia, atrioventricular nodal reentrant tachycardia and interatrial conduction block.

Authors:  J Schreieck; B Zrenner; J Dong; G Ndrepepa; C Schmitt
Journal:  Z Kardiol       Date:  2002-01

8.  Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.

Authors:  Philipp Schütt; Peter Ebeling; Ulrike Buttkereit; Dieter Brandhorst; Bertram Opalka; Miriam Poser; Siemke Müller; Michael Flasshove; Thomas Moritz; Siegfried Seeber; Mohammad Resa Nowrousian
Journal:  Ann Hematol       Date:  2005-03-03       Impact factor: 3.673

9.  Thalidomide-induced sinus bradycardia.

Authors:  Amandeep Kaur; Susan S Yu; Audrey J Lee; Teresa B Chiao
Journal:  Ann Pharmacother       Date:  2003 Jul-Aug       Impact factor: 3.154

10.  Thalidomide is an inhibitor of angiogenesis.

Authors:  R J D'Amato; M S Loughnan; E Flynn; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205
View more
  3 in total

1.  Thalidomide-induced heart block in a dialysis patient.

Authors:  Siddiq Anwar; Kunal Chawathey; Steve Holt
Journal:  NDT Plus       Date:  2009-12

2.  Myocardial infarction, symptomatic third degree atrioventricular block and pulmonary embolism caused by thalidomide: a case report.

Authors:  Shengyu Zhang; Jing Yang; Xiaofeng Jin; Shuyang Zhang
Journal:  BMC Cardiovasc Disord       Date:  2015-12-18       Impact factor: 2.298

3.  Bradyarrhythmias in Cardio-Oncology.

Authors:  Marta Fonseca; Evaline Cheng; Duc Do; Shouvik Haldar; Shelby Kutty; Eric H Yang; Arjun K Ghosh; Avirup Guha
Journal:  South Asian J Cancer       Date:  2021-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.